|
Cancer-Med What we do, what we offer
On this site we describe our efforts to develop co-bodies for cancer research and (hopefully, soon) treatment, provide information for the public about progress in cancer research and treatment generally, offer services and opportunities for participation. Subscribers to our CanChure program will have access to advice and information more or less freely, depending on the service level chosen. At the highest level, members will have the right to personal advice by telephone or email, at any time, any day; at the lowest, subscribers will have access to news about progress, well in advance of any public announcement.
Cancer-Med is a joint enterprise between Hybrid Antibodies Ltd and 21st Century Clinic Ltd, seeking to introduce a particular invention for use in cancer diagnosis and treatment, when justified and as soon as may be. So this site expresses a definite special interest. We concentrate on topics related to the future role of co-bodies, and about our activities to develop and promote their use.
Other pages
Reality: Cancer treatment today, hope for tomorrow, possible role of co-bodies.
Discovery: How co-bodies were invented.
Delivery: What we are doing to develop co-bodies and inform the public.
CanChure: Details of the program. How to subscribe.
Progress: Non-technical information about progress and plans.
Research: Recent research on cancer relating to how co-bodies may come to play a part. The discussion here may be seriously technical and/or refer to the original scientific literature
Other sites
www.cancerinfo.be gives the cancer story in a balanced and neutral way, with a minimum of technical language though enough to understand the difficulties.
www.hybridantibodies.com is the website of Hybrid Antibody Technology Ltd. Co-bodies are explained there in a more technical way than is possible here, and also their applications in other fields of science, technology and industry. Co-bodies are not confined to use in cancer treatment! Investment is needed and enquiries are invited.
|